TCL Archive Reed To Leave NCI Next Year; Allegra Moves To Extramural Side; Ozer Heads Okla. Center. July 21, 2000
TCL Archive Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival April 27, 2012
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Tobacco Interests Contribute a Portion Of the $109 Million Raised by Stand Up To Cancer September 12, 2014
